Moxifloxacin - PDFSEARCH.IO - Document Search Engine

Moxifloxacin
Results: 290

#	Item
51	EV-035: Novel 2-pyridone based topoisomerase inhibitors with broad-spectrum activity against MDR pathogens, including quinolone resistance F-2030 52nd ICAAC 2012 Add to Reading List Source URL: www.evolva.com Language: English - Date: 2012-09-13 02:28:15 Bacteria Microbiology Cyclopropanes Otologicals Antibiotics Levofloxacin Moxifloxacin Pefloxacin Antibiotic resistance Piperazines Medicine Chemistry
52	Rationale for the EUCAST clinical breakpoints Add to Reading List Source URL: www.eucast.org Language: English - Date: 2009-12-12 17:13:00 Bacteria Pefloxacin Moxifloxacin Norfloxacin Community-acquired pneumonia Levofloxacin Ofloxacin Streptococcus Quinolone Piperazines Chemistry Organic chemistry
53	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use MOXEZA® solution safely and effectively. See full prescribing information for MOXEZA®. MOXEZA® (moxifloxacin hydr Add to Reading List Source URL: ecatalog.alcon.com Language: English - Date: 2014-08-21 13:04:53 Cyclopropanes Piperazines Moxifloxacin Otologicals Quinolone Peptostreptococcus Ofloxacin Klebsiella pneumoniae Staphylococcus Bacteria Organic chemistry Chemistry
54	Version 1.2 April[removed]EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Add to Reading List Source URL: www.eucast.org Language: English - Date: 2010-04-27 06:02:17 Chemistry Gram-negative bacteria Biology Beta-lactamase Ciprofloxacin Clavulanic acid Moxifloxacin Pseudomonas aeruginosa Epsilometer test Cyclopropanes Microbiology Organic chemistry
55	Rational use of moxifloxacin for tuberculosis treatment Add to Reading List Source URL: fieldresearch.msf.org Language: English - Date: 2011-05-23 23:17:27 Microbiology Extensively drug-resistant tuberculosis Tuberculosis treatment Multi-drug-resistant tuberculosis TB Alliance AIDS Antiretroviral drug Directly Observed Therapy – Short Course Partners In Health Tuberculosis Health Medicine
56	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TASIGNA safely and effectively. See full prescribing information for TASIGNA. TASIGNA® (nilotinib) Capsules for ora Add to Reading List Source URL: www.pharma.us.novartis.com Language: English - Date: 2015-01-30 17:11:38 Organofluorides Pyrimidines Pyridines Alcohols Imatinib Chronic myelogenous leukemia Pimozide Norfloxacin Moxifloxacin Organic chemistry Chemistry Piperazines
57	FDA Briefing Document Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee (ODAC) December 11, 2014 DISCLAIMER STATEMENT Add to Reading List Source URL: www.fda.gov Language: English Clinical pharmacology Food and Drug Administration Therapeutics United States Public Health Service Biosimilar Off-label use Food and Drug Administration Amendments Act Moxifloxacin Pharmacology Pharmaceutical sciences Clinical research
58	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use DALVANCE™ safely and effectively. See full prescribing information for DALVANCE. DALVANCE (dalbavancin) for inject Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-05-28 14:11:06 Organofluorides Cyclopropanes Dalbavancin Moxifloxacin Linezolid Azithromycin Flucytosine Daptomycin Chemistry Pfizer Organic chemistry
59	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AVELOX safely and effectively. See full prescribing information for AVELOX. -------------------------------CONTRAIN Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-11-21 12:58:24 Bacteria Cyclopropanes Moxifloxacin Otologicals Quinolone Ofloxacin Quinolone antibiotics Klebsiella pneumoniae Clostridium difficile Chemistry Organic chemistry Piperazines
60	Off-Label: Just What the Doctor Ordered Add to Reading List Source URL: www.intranasal.net Language: English - Date: 2008-09-17 18:31:32 Pharmaceutical sciences Off-label use Food and Drug Administration Package insert Prescription medication Investigational New Drug Pharmaceutical industry Adverse effect Moxifloxacin Medicine Pharmacology Health